These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9758052)

  • 21. Vancomycin-resistant enterococci in intensive care hospital settings.
    Austin DJ; Bonten MJ
    Mem Inst Oswaldo Cruz; 1998; 93(5):587-8. PubMed ID: 9830522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions.
    Lai KK; Kelley AL; Melvin ZS; Belliveau PP; Fontecchio SA
    Infect Control Hosp Epidemiol; 1998 Sep; 19(9):647-52. PubMed ID: 9778162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin-resistant enterococcus in end-stage renal disease.
    Brady JP; Snyder JW; Hasbargen JA
    Am J Kidney Dis; 1998 Sep; 32(3):415-8. PubMed ID: 9740157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vancomycin resistant enterococci in the Netherlands].
    Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin-resistant enterococci in neonates.
    Yüce A; Karaman M; Gülay Z; Yulug N
    Scand J Infect Dis; 2001; 33(11):803-5. PubMed ID: 11760156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing the spread of vancomycin-resistant enterococci in a long-term care facility.
    Silverblatt FJ; Tibert C; Mikolich D; Blazek-D'Arezzo J; Alves J; Tack M; Agatiello P
    J Am Geriatr Soc; 2000 Oct; 48(10):1211-5. PubMed ID: 11037006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients.
    Simonsen GS; Andersen BM; Digranes A; Harthug S; Jacobsen T; Lingaas E; Natås OB; Olsvik O; Ringertz SH; Skulberg A; Syversen G; Sundsfjord A
    Scand J Infect Dis; 1998; 30(5):465-8. PubMed ID: 10066045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling the regional spread and control of vancomycin-resistant enterococci.
    Lee BY; Yilmaz SL; Wong KF; Bartsch SM; Eubank S; Song Y; Avery TR; Christie R; Brown ST; Epstein JM; Parker JI; Huang SS
    Am J Infect Control; 2013 Aug; 41(8):668-73. PubMed ID: 23896284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong.
    Cheng VC; Tai JW; Chen JH; So SY; Ng WC; Hung IF; Leung SS; Wong SC; Chan TC; Chan FH; Ho PL; Yuen KY
    J Formos Med Assoc; 2014 Oct; 113(10):734-41. PubMed ID: 24796821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility.
    Armstrong-Evans M; Litt M; McArthur MA; Willey B; Cann D; Liska S; Nusinowitz S; Gould R; Blacklock A; Low DE; McGeer A
    Infect Control Hosp Epidemiol; 1999 May; 20(5):312-7. PubMed ID: 10349946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vancomycin resistant enterococci in Austria].
    Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci.
    Shay DK; Goldmann DA; Jarvis WR
    Pediatr Clin North Am; 1995 Jun; 42(3):703-16. PubMed ID: 7761148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].
    Atalay S; Ece G; Samlıoğlu P; Maraş G; Köse I; Köse S
    Mikrobiyol Bul; 2012 Oct; 46(4):553-9. PubMed ID: 23188569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for the prevention and control of vancomycin resistant enterococci (VRE) in long-term care facilities. Sioux Falls Task Force on Antimicrobial Resistance.
    S D J Med; 1998 Apr; 51(4):127-32. PubMed ID: 9577692
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci.
    Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):709-15. PubMed ID: 18631116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin-resistant Enterococci. Prevalence and risk factors for fecal carriage in patients at tertiary care hospitals.
    El-Amin NM; Faidah HS
    Saudi Med J; 2011 Sep; 32(9):966-7. PubMed ID: 21894365
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vancomycin-resistant enterococcus--chronicle of a foretold problem].
    Bonten MJ; Willems RJ
    Ned Tijdschr Geneeskd; 2012; 156(38):A5233. PubMed ID: 22992249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.
    Hagman HM; Strausbaugh LJ
    Postgrad Med; 1996 May; 99(5):60-5, 69-71. PubMed ID: 8650096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin-resistant Enterococci in Singaporean hospitals: 5-year results of a multi-centre surveillance programme.
    Cai Y; Chan JP; Fisher DA; Hsu LY; Koh TH; Krishnan P; Kwa AL; Tan TY; Tee NW
    Ann Acad Med Singap; 2012 Feb; 41(2):77-81. PubMed ID: 22498854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin-resistant enterococci: why are they here, and where do they come from?
    Bonten MJ; Willems R; Weinstein RA
    Lancet Infect Dis; 2001 Dec; 1(5):314-25. PubMed ID: 11871804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.